Proceeds from its fresh issuance will be utilised for setting up a manufacturing facility for the production of sterile injections in its Atlanta facility; funding the working capital requirements of the company and its subsidiaries; supporting inorganic growth through acquisition and other strategic initiatives and payment of debt. Besides, a portion will be used for general corporate purposes.
Concentra, founded in 1979, is now the largest provider of occupational health services in the United States by number of locations, according to its IPO prospectus.
The occupational health services company is aiming to sell 22.50 million shares in the offering, priced between $23 and $26 apiece, to raise as much as $585 million, it revealed in a regulatory filing on Monday.
After a two-year dry spell, the IPO market is on the road to recovery, helped by firming bets of a soft landing for the world's largest economy and increasing investor appetite for new listings.
arlier this month, the company received Sebi's go-ahead to float the initial share sale. Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue. The equity shares of the company are expected to list on the BSE and NSE on July 10.
Delius Pharmaceuticals has said that it has registered a 35 percent increase in sales and turnover in FY 23-24. The API division has also registered a remarkable growth of 60 percent, the company said. "This success isn't just about financial growth; it's a tale of dedication to producing top-notch pharmaceuticals," the company said, announcing its performance. It also announced plans to launch an IPO in the next few years.
The Kolkata-headquartered Nephrocare is a healthcare provider that specialises in the treatment of kidney-related diseases. It currently provides healthcare services to patients at its flagship Salt Lake clinic, and two satellite clinics at Salt Lake (HB 113) and Chandannagar, near Kolkata.
The company's shares opened at $23 apiece, above their initial public offering (IPO) price of $21. PACS raised $450 million on Wednesday from the sale of 21.4 million shares in an upsized offering.
The Reserve Bank of India (RBI) announced that the transaction limit to Rs 5 lakh for UPI payments to hospitals and educational institutions on December 8, 2023. The National Payment Corporation of India (NPCI) has asked banks, PSPs (Payment Service Provider), and APs to make it available by January 10, 2024.
Agilus Diagnostics, formerly known as SRL Ltd, is one of the largest diagnostics service providers in terms of number of laboratories and the second largest in terms of revenue from operations in India, as of financial year ended March 31, 2023, according to a Crisil report.
Prior to its Initial Public Offering (IPO), Jupiter Life Line Hospitals reported on Tuesday that it had secured Rs 261 crore from anchor investors. The deal from the multi-specialty hospital network will go on sale on Wednesday. A circular posted on the BSE website states that the business has opted to distribute 35.47 lakh equity shares to 39 entities at a price of Rs. 735 per share, which is also the upper limit of the price range.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
